SlideShare a Scribd company logo
1 of 6
Risk Prediction: XynChart vs SRTR

Scenario 1:                     1-Year Success (%)
                         100%
• 58 year old male
• ESRD from PCD           95%

• No dialysis             90%

• Non-Smoker              85%

• BMI 27                  80%

                          75%
                                Graft Success Patient Survival
                                   SRTR    XynChart
Risk Prediction: XynChart vs SRTR

Scenario 2:                       1-Year Success (%)
                           100%
• 58 year old male
• ESRD from Hypertension   95%

• Type II DM (Oral Meds)   90%

• No dialysis              85%

• Non-Smoker               80%

• BMI 33                   75%
                                  Graft Success Patient Survival
                                     SRTR    XynChart
Risk Prediction: XynChart vs SRTR

Scenario 3:                       1-Year Success (%)
                           100%
• 58 year old male
• ESRD from Hypertension   95%

• Type II DM (Insulin)     90%

• No dialysis              85%

• Current Smoker           80%

• BMI 33                   75%
• Prior MI                        Graft Success Patient Survival
                                     SRTR    XynChart
Risk Prediction: XynChart vs SRTR

Scenario 4:                       1-Year Success (%)
                           100%
• 58 year old male
• ESRD from Hypertension   95%

• Type II DM (Insulin)     90%

• 3 years of dialysis      85%

• Current Smoker           80%

• BMI 33                   75%
• Prior MI                        Graft Success Patient Survival
                                  SRTR Graft    Xyn Graft
Risk Prediction: XynChart vs SRTR

Scenario 5:                              1-Year Success (%)
•   58 year old male              100%
•   ESRD from Hypertension        95%
•   Type II DM (Insulin)
•   3 years of dialysis           90%

•   Current Smoker                85%
•   BMI 33
                                  80%
•   Prior MI
•   COPD                          75%
•   Prior stoke, no deficit but          Graft Success Patient Survival
    on anticoagulation                      SRTR    XynChart
Risk Prediction: XynChart vs SRTR
 SRTR does not accurately reflect the clearly increasing risks in
 these scenarios. XynChart gives you better insight.
          SRTR Predictions                       XynChart Predictions
          1-Year Success (%)                        1-Year Success (%)
100%                                      100%
95%                                       95%
90%                                       90%
85%                                       85%
80%                                       80%
75%                                       75%
           1     2     3      4      5               1      2        3     4      5
                 Scenarios                                       Scenarios
       Graft Success   Patient Survival          Graft Success      Patient Survival

More Related Content

Similar to Example 2 rjw

Radiotherapy Lymphomas
Radiotherapy LymphomasRadiotherapy Lymphomas
Radiotherapy Lymphomas
fondas vakalis
 
Oncotype Dx Mammaprint
Oncotype Dx MammaprintOncotype Dx Mammaprint
Oncotype Dx Mammaprint
fondas vakalis
 

Similar to Example 2 rjw (13)

Salivary glands cancer
Salivary glands cancerSalivary glands cancer
Salivary glands cancer
 
Radiotherapy Lymphomas
Radiotherapy LymphomasRadiotherapy Lymphomas
Radiotherapy Lymphomas
 
Seminar high grade glioma
Seminar high grade gliomaSeminar high grade glioma
Seminar high grade glioma
 
Thyroid cancer and it’s types. oncology
Thyroid cancer and it’s types.  oncologyThyroid cancer and it’s types.  oncology
Thyroid cancer and it’s types. oncology
 
Ca thyroid
Ca thyroidCa thyroid
Ca thyroid
 
Management of testicular cancers
Management of testicular cancersManagement of testicular cancers
Management of testicular cancers
 
Oncotype Dx Mammaprint
Oncotype Dx MammaprintOncotype Dx Mammaprint
Oncotype Dx Mammaprint
 
Adjuvant Treatment in Meningioma
Adjuvant Treatment in MeningiomaAdjuvant Treatment in Meningioma
Adjuvant Treatment in Meningioma
 
Chronic myeloid leukemia
Chronic myeloid leukemiaChronic myeloid leukemia
Chronic myeloid leukemia
 
Axillary radiotherapy versus axillary surgery in breast cancer
Axillary radiotherapy versus axillary surgery in breast cancerAxillary radiotherapy versus axillary surgery in breast cancer
Axillary radiotherapy versus axillary surgery in breast cancer
 
Testicular Tumors.pptx
Testicular Tumors.pptxTesticular Tumors.pptx
Testicular Tumors.pptx
 
sacrococcygeal teratoma
sacrococcygeal teratomasacrococcygeal teratoma
sacrococcygeal teratoma
 
Why cervical cancer prevention need
Why cervical cancer prevention needWhy cervical cancer prevention need
Why cervical cancer prevention need
 

Example 2 rjw

  • 1. Risk Prediction: XynChart vs SRTR Scenario 1: 1-Year Success (%) 100% • 58 year old male • ESRD from PCD 95% • No dialysis 90% • Non-Smoker 85% • BMI 27 80% 75% Graft Success Patient Survival SRTR XynChart
  • 2. Risk Prediction: XynChart vs SRTR Scenario 2: 1-Year Success (%) 100% • 58 year old male • ESRD from Hypertension 95% • Type II DM (Oral Meds) 90% • No dialysis 85% • Non-Smoker 80% • BMI 33 75% Graft Success Patient Survival SRTR XynChart
  • 3. Risk Prediction: XynChart vs SRTR Scenario 3: 1-Year Success (%) 100% • 58 year old male • ESRD from Hypertension 95% • Type II DM (Insulin) 90% • No dialysis 85% • Current Smoker 80% • BMI 33 75% • Prior MI Graft Success Patient Survival SRTR XynChart
  • 4. Risk Prediction: XynChart vs SRTR Scenario 4: 1-Year Success (%) 100% • 58 year old male • ESRD from Hypertension 95% • Type II DM (Insulin) 90% • 3 years of dialysis 85% • Current Smoker 80% • BMI 33 75% • Prior MI Graft Success Patient Survival SRTR Graft Xyn Graft
  • 5. Risk Prediction: XynChart vs SRTR Scenario 5: 1-Year Success (%) • 58 year old male 100% • ESRD from Hypertension 95% • Type II DM (Insulin) • 3 years of dialysis 90% • Current Smoker 85% • BMI 33 80% • Prior MI • COPD 75% • Prior stoke, no deficit but Graft Success Patient Survival on anticoagulation SRTR XynChart
  • 6. Risk Prediction: XynChart vs SRTR SRTR does not accurately reflect the clearly increasing risks in these scenarios. XynChart gives you better insight. SRTR Predictions XynChart Predictions 1-Year Success (%) 1-Year Success (%) 100% 100% 95% 95% 90% 90% 85% 85% 80% 80% 75% 75% 1 2 3 4 5 1 2 3 4 5 Scenarios Scenarios Graft Success Patient Survival Graft Success Patient Survival